Is EDETATE DISODIUM Safe? — Ingredient Safety Profile · Greenveil
Ingredients EDETATE DISODIUM beauty / cleaning / food / industrial / pharma
EDETATE DISODIUM EPA CPDat observed this chemical in 171 composition records across product categories including Laboratory supplies, Food and drug, Pet and animal care.
Research docs 0 Claims 0 Sources 80 Function Antioxidant • Chelating agent Identifier DTXSID5049576 45
Concern score
45/100 Moderate concern based on regulatory listings.
How we scored this The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Where it appears Prevalence of EDETATE DISODIUM in our catalog (epa_cpdat).
Laboratory supplies Food and drug Pet and animal care Personal care
Typical roles
Antioxidant Chelating agent Flavouring and nutrient Fragrance
See products using EDETATE DISODIUM → Suitability Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
Linked research Primary documents currently linked to this ingredient record.
No linked research documents are attached to this ingredient yet.
Extracted claims Structured claim signals pulled from linked ingredient research.
No extracted claims are attached to this ingredient yet.
Regulatory status Published jurisdiction-level classifications and regulatory designations for this ingredient.
EPA CPDat observed this chemical in 171 composition records across product categories including Laboratory supplies, Food and drug, Pet and animal care. EPA CPDat classifies this chemical for functional uses including Fragrance, Antioxidant, Chelating agent.
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 0.05 %w/w
inactive ingredient database The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
Evidence read The published evidence profile currently shaping this ingredient record.
No evidence profiles are attached to this ingredient yet.
Route: AURICULAR (OTIC); Dosage form: SOLUTION; Potency: 0.1 %w/v
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SUSPENSION; Potency: 0.01 %w/v
inactive ingredient database Route: AURICULAR (OTIC); Dosage form: SUSPENSION/ DROPS; Potency: 0.01 %w/v
inactive ingredient database Route: INFILTRATION; Dosage form: INJECTION; Maximum daily exposure: 6 mg
inactive ingredient database Route: INTRA-ARTICULAR; Dosage form: INJECTION; Potency: 0.05 %w/v
inactive ingredient database Route: INTRABURSAL; Dosage form: INJECTION; Potency: 0.01 %w/v
inactive ingredient database Route: INTRACARDIAC; Dosage form: INJECTION; Maximum daily exposure: 2 mg
inactive ingredient database Route: INTRALESIONAL; Dosage form: INJECTION; Potency: 0.05 %w/v
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 10 %w/v
inactive ingredient database Route: INTRAMUSCULAR; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 4 mg
inactive ingredient database Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: 0.48 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 10 %w/v
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Maximum daily exposure: 59 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SOLUTION; Maximum daily exposure: 6 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, FOR SUSPENSION; Potency: 0.4 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 19 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 7 mg
inactive ingredient database Route: INTRAVENOUS; Dosage form: LIQUID; Potency: 0.03 %w/v
inactive ingredient database Route: INTRAVENOUS; Dosage form: SOLUTION; Potency: 0.05 %w/v
inactive ingredient database Route: IONTOPHORESIS; Dosage form: SYSTEM; Potency: 0.1 mg
inactive ingredient database Route: NASAL; Dosage form: DROPS; Potency: 0.1 mg/1ml
inactive ingredient database Route: NASAL; Dosage form: LIQUID; Potency: 2 mg/1ml
inactive ingredient database Route: NASAL; Dosage form: SOLUTION; Potency: 100 mg/100ml
inactive ingredient database Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 1 mg
inactive ingredient database Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 4 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: DROPS; Potency: 0.05 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: EMULSION; Potency: 0.3 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 396 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 4 mg
inactive ingredient database Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.13 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.06 %w/v
inactive ingredient database Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 1 mg
inactive ingredient database Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 5 mg
inactive ingredient database Route: ORAL; Dosage form: CONCENTRATE; Maximum daily exposure: 20 mg
inactive ingredient database Route: ORAL; Dosage form: ELIXIR; Potency: 1.3 mg/5ml
inactive ingredient database Route: ORAL; Dosage form: LIQUID; Potency: 0.5 mg/1ml
inactive ingredient database Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 285 mg
inactive ingredient database Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 432 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 30 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 40 mg
inactive ingredient database Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 4 mg
inactive ingredient database Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 40 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 100 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, COATED; Potency: 0.21 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 100 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EFFERVESCENT; Maximum daily exposure: 32 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 10 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 4 mg
inactive ingredient database Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 3 mg
inactive ingredient database Route: RECTAL; Dosage form: AEROSOL, FOAM; Maximum daily exposure: 2 mg
inactive ingredient database Route: RECTAL; Dosage form: ENEMA; Maximum daily exposure: 60 mg
inactive ingredient database Route: RECTAL; Dosage form: SOLUTION; Maximum daily exposure: 97 mg
inactive ingredient database Route: RESPIRATORY (INHALATION); Dosage form: SOLUTION; Maximum daily exposure: 43 mg
inactive ingredient database Route: RESPIRATORY (INHALATION); Dosage form: SPRAY; Potency: 0.05 %w/w
inactive ingredient database Route: RESPIRATORY (INHALATION); Dosage form: SUSPENSION; Potency: 0.01 %w/v
inactive ingredient database Route: SOFT TISSUE; Dosage form: INJECTION; Potency: 0.05 %w/v
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION; Maximum daily exposure: 6 mg
inactive ingredient database Route: SUBCUTANEOUS; Dosage form: INJECTION, SOLUTION; Maximum daily exposure: 2 mg
inactive ingredient database Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 0.05 %w/w
inactive ingredient database Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 14 mg
inactive ingredient database Route: TOPICAL; Dosage form: CREAM, AUGMENTED; Maximum daily exposure: 2 mg
inactive ingredient database Route: TOPICAL; Dosage form: EMULSION; Potency: 0.11 %w/w
inactive ingredient database Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 7 mg
inactive ingredient database Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 22 mg
inactive ingredient database Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 1 mg
inactive ingredient database Route: TOPICAL; Dosage form: SHAMPOO; Potency: 1 %w/w
inactive ingredient database Route: TOPICAL; Dosage form: SHAMPOO, SUSPENSION; Potency: 1 %w/w
inactive ingredient database Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 1 mg
inactive ingredient database Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 126 mg
inactive ingredient database Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 1 mg
inactive ingredient database Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 3 mg
inactive ingredient database Route: VAGINAL; Dosage form: GEL; Maximum daily exposure: 5 mg
FDA NDC lists this ingredient in 2 active drug products and 2 total products.
listed in openFDA substance openFDA substance registry classifies this ingredient as chemical.
